100 related articles for article (PubMed ID: 15725471)
1. Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia.
Sokol L; Agrawal D; Loughran TP
Leuk Res; 2005 Apr; 29(4):381-7. PubMed ID: 15725471
[TBL] [Abstract][Full Text] [Related]
2. Seroreactivity to an envelope protein of human T-cell leukemia/lymphoma virus in patients with CD3- (natural killer) lymphoproliferative disease of granular lymphocytes.
Loughran TP; Hadlock KG; Yang Q; Perzova R; Zambello R; Semenzato G; Foung SK; Poiesz BJ
Blood; 1997 Sep; 90(5):1977-81. PubMed ID: 9292532
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia.
Loughran TP; Hadlock KG; Perzova R; Gentile TC; Yang Q; Foung SK; Poiesz BJ
Br J Haematol; 1998 May; 101(2):318-24. PubMed ID: 9609528
[TBL] [Abstract][Full Text] [Related]
4. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):1-6. PubMed ID: 11708767
[TBL] [Abstract][Full Text] [Related]
5. Chimeric synthetic peptides from the envelope (gp46) and the transmembrane (gp21) glycoproteins for the detection of antibodies to human T-cell leukemia virus type II.
Hernández Marin M; Castellanos Pentón P; Márquez Bocalandro Y; Pozo Peña L; Díaz Navarro J; González López LJ
Biochem Biophys Res Commun; 2001 Nov; 289(1):7-12. PubMed ID: 11708768
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins.
Kurihara K; Shimizu Y; Takamori A; Harashima N; Noji M; Masuda T; Utsunomiya A; Okamura J; Kannagi M
J Immunol Methods; 2006 Jun; 313(1-2):61-73. PubMed ID: 16723135
[TBL] [Abstract][Full Text] [Related]
7. HTLV-1 and -2 envelope SU subdomains and critical determinants in receptor binding.
Kim FJ; Manel N; Garrido EN; Valle C; Sitbon M; Battini JL
Retrovirology; 2004 Dec; 1():41. PubMed ID: 15575958
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity of chimeric synthetic peptides based on HTLV-1 antigens and the impact of epitope orientation.
Hernández M; Selles ME; Pozo Peña L; Gómez I; Melchor A
Biochem Biophys Res Commun; 2000 Oct; 276(3):1085-8. PubMed ID: 11027594
[TBL] [Abstract][Full Text] [Related]
9. Current concepts: large granular lymphocyte leukemia.
Lamy T; Loughran TP
Blood Rev; 1999 Dec; 13(4):230-40. PubMed ID: 10741898
[TBL] [Abstract][Full Text] [Related]
10. The human T-cell lymphotropic viruses types I/II are not involved in T prolymphocytic leukemia and large granular lymphocytic leukemia.
Pawson R; Schulz TF; Matutes E; Catovsky D
Leukemia; 1997 Aug; 11(8):1305-11. PubMed ID: 9264385
[TBL] [Abstract][Full Text] [Related]
11. Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study.
Nyland SB; Krissinger DJ; Clemente MJ; Irby RB; Baab KT; Jarbadan NR; Sokol L; Schaefer E; Liao J; Cuthbertson D; Epling-Burnette P; Paquette R; List AF; Maciejewski JP; Loughran TP
Leuk Res; 2012 May; 36(5):581-7. PubMed ID: 22386729
[TBL] [Abstract][Full Text] [Related]
12. The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax.
Chevalier SA; Meertens L; Pise-Masison C; Calattini S; Park H; Alhaj AA; Zhou M; Gessain A; Kashanchi F; Brady JN; Mahieux R
Oncogene; 2006 Jul; 25(32):4470-82. PubMed ID: 16532031
[TBL] [Abstract][Full Text] [Related]
13. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
Kozako T; Fukada K; Hirata S; White Y; Harao M; Nishimura Y; Kino Y; Soeda S; Shimeno H; Lemonnier F; Sonoda S; Arima N
Mol Immunol; 2009 Dec; 47(2-3):606-13. PubMed ID: 19889459
[TBL] [Abstract][Full Text] [Related]
14. [Expression of a fragment of the env gene, coding for the GP46 surface glycoprotein of the human T-cell leukemia virus, in Escherichia coli cells].
Bondarenko VO; Kazennova EV; Bobkova MR; Prilipov AG; Bobkov AF
Mol Gen Mikrobiol Virusol; 2000; (3):33-6. PubMed ID: 10975079
[TBL] [Abstract][Full Text] [Related]
15. Human T-cell lymphotropic virus type 1 provirus and phylogenetic analysis in patients with mycosis fungoides and their family relatives.
Shohat M; Shohat B; Mimouni D; Pauli G; Ellerbrok H; David M; Hodak E
Br J Dermatol; 2006 Aug; 155(2):372-8. PubMed ID: 16882177
[TBL] [Abstract][Full Text] [Related]
16. Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates.
Kim FJ; Lavanya M; Gessain A; Gallego S; Battini JL; Sitbon M; Courgnaud V
Retrovirology; 2006 May; 3():29. PubMed ID: 16725042
[TBL] [Abstract][Full Text] [Related]
17. Isolated receptor binding domains of HTLV-1 and HTLV-2 envelopes bind Glut-1 on activated CD4+ and CD8+ T cells.
Kinet S; Swainson L; Lavanya M; Mongellaz C; Montel-Hagen A; Craveiro M; Manel N; Battini JL; Sitbon M; Taylor N
Retrovirology; 2007 May; 4():31. PubMed ID: 17504522
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antigenic sites of the envelope glycoprotein of the Iranian isolate of human T-cell leukemia virus type 1 with different subtypes of the virus.
Mohabatkar H; Sadeghi S
Saudi Med J; 2006 Aug; 27(8):1121-4. PubMed ID: 16883437
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
Gustchina E; Hummer G; Bewley CA; Clore GM
J Med Chem; 2005 Apr; 48(8):3036-44. PubMed ID: 15828842
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
Gergely P; Pullmann R; Stancato C; Otvos L; Koncz A; Blazsek A; Poor G; Brown KE; Phillips PE; Perl A
Clin Immunol; 2005 Aug; 116(2):124-34. PubMed ID: 15894513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
